American pharma giants are increasingly turning to Chinese labs to discover, test and develop cutting-edge drugs.

On today’s Big Take Asia podcast, Bloomberg’s Amber Tong and Robert Langreth join Oanh Ha to break down why global drugmakers are sourcing their next big breakthroughs from China — and what that means for US biotech dominance.

Read more: Big Pharma Is Hooked on Chinese Licensing Deals

Hosted by K. Oanh Ha; Produced by Naomi Ng and David Fox; Guests: Amber Tong and Robert Langreth; Edited by Paddy Hirsch and Crispina Robert.

Fact-checking by Brunella Tipismana Urbano; Engineering by Alex Suguira.

Senior Producer: Naomi Shavin; Deputy Executive Producer: Julia Weaver. Executive Producer: Nicole Beemsterboer.

See omnystudio.com/listener for privacy information.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Bloomberg. Innehållet i podden är skapat av Bloomberg och inte av, eller tillsammans med, Poddtoppen.